- Home
- AMOD vs PRPH Comparison
AMOD vs PRPH Comparison
Compare AMOD & PRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMOD
- PRPH
- Stock Information
- Founded
- AMOD 2014
- PRPH 1989
- Country
- AMOD United States
- PRPH United States
- Employees
- AMOD N/A
- PRPH N/A
- Industry
- AMOD
- PRPH Biotechnology: Pharmaceutical Preparations
- Sector
- AMOD
- PRPH Health Care
- Exchange
- AMOD NYSE
- PRPH Nasdaq
- Market Cap
- AMOD 18.7M
- PRPH 17.7M
- IPO Year
- AMOD N/A
- PRPH 1997
- Fundamental
- Price
- AMOD $1.39
- PRPH $0.47
- Analyst Decision
- AMOD
- PRPH
- Analyst Count
- AMOD 0
- PRPH 0
- Target Price
- AMOD N/A
- PRPH N/A
- AVG Volume (30 Days)
- AMOD 7.4M
- PRPH 930.1K
- Earning Date
- AMOD 08-15-2025
- PRPH 08-13-2025
- Dividend Yield
- AMOD N/A
- PRPH N/A
- EPS Growth
- AMOD N/A
- PRPH N/A
- EPS
- AMOD 0.12
- PRPH N/A
- Revenue
- AMOD N/A
- PRPH $5,845,000.00
- Revenue This Year
- AMOD N/A
- PRPH $221.82
- Revenue Next Year
- AMOD N/A
- PRPH N/A
- P/E Ratio
- AMOD $11.70
- PRPH N/A
- Revenue Growth
- AMOD N/A
- PRPH N/A
- 52 Week Low
- AMOD $1.01
- PRPH $0.22
- 52 Week High
- AMOD $13.49
- PRPH $3.37
- Technical
- Relative Strength Index (RSI)
- AMOD N/A
- PRPH 63.66
- Support Level
- AMOD N/A
- PRPH $0.32
- Resistance Level
- AMOD N/A
- PRPH $0.45
- Average True Range (ATR)
- AMOD 0.00
- PRPH 0.04
- MACD
- AMOD 0.00
- PRPH 0.00
- Stochastic Oscillator
- AMOD 0.00
- PRPH 90.27
About AMOD ALPHA MODUS HOLDINGS INC
Alpha Modus Holdings Inc is a technology company with a core focus on artificial intelligence in retail. It is engaged in creating, developing, and licensing data-driven technologies to enhance consumers' in-store digital experience at the point of decision.
About PRPH ProPhase Labs Inc. (DE)
ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.